Collagen is not a single molecule but a family of related proteins, and Type II is the form found almost exclusively in cartilage. Unlike Type I collagen, which is the dominant structural protein in skin, bone, and tendons, Type II collagen makes up the majority of the collagen fibers within joint cartilage, giving cartilage its ability to resist compression and maintain shape under repeated mechanical load.
Most Type II collagen used in supplements is derived from chicken sternum cartilage, with undenatured type II collagen (often referred to by the ingredient name UC-II) being one of the most researched and widely used forms in the joint health category. This distinguishes it from Type I collagen, which is more commonly sourced from fish skin or bovine hide.
Type II collagen forms a dense network of fibers within cartilage tissue, working alongside proteoglycans to create a matrix that cushions joints and allows smooth, low-friction movement between bones. As this collagen network naturally wears down with age or repetitive joint stress, cartilage becomes less resilient, which is commonly associated with reduced joint comfort and flexibility.
There are two main approaches to Type II collagen supplementation. Undenatured Type II collagen preserves the protein's native structure and is thought to work through a mechanism called oral tolerization, in which small daily doses interact with gut-associated immune tissue to help modulate the body's inflammatory response toward joint tissue. Hydrolyzed Type II collagen, by contrast, is broken down into smaller peptides, similar in concept to hydrolyzed Type I collagen, and is thought to work more through providing raw materials that support the body's own cartilage matrix production.
Type II collagen is almost exclusively formulated into joint health and mobility products, often at notably lower daily doses than Type I collagen (commonly in the tens of milligrams for undenatured forms, versus grams for hydrolyzed Type I). It is frequently paired with ingredients such as glucosamine, chondroitin, or hyaluronic acid in combination joint-support formulas.
For B2B buyers and formulators, confusing Type I and Type II collagen can lead to mismatched product claims and underperforming formulations. A few key distinctions to keep in mind:
▸ Target tissue: Type I supports skin, bone, hair, and general connective tissue; Type II is specific to cartilage and joint function.
▸ Typical source: Type II is most commonly derived from chicken cartilage, while Type I is widely sourced from fish skin or bovine hide.
▸ Dosage and mechanism: Type II is often used at low doses via an immune-modulation mechanism (undenatured form), while Type I is typically dosed at higher gram-level amounts as a direct peptide supply.
▸ Marketing claims: A skin-elasticity claim built on Type I research should not be applied to a Type II ingredient, and vice versa for joint-specific claims — the clinical evidence behind each type is largely non-interchangeable.
Before selecting a collagen ingredient, it is worth working backward from the intended product claim. Formulations built around joint comfort and mobility are generally better served by Type II collagen, while products targeting skin, hair, nails, or general connective tissue support are more appropriately built on Type I collagen peptides.
At HS Nutra, we specialize in Type I marine collagen peptides sourced from deep-sea cod and premium freshwater tilapia, hydrolyzed under controlled conditions and verified through third-party testing for molecular weight and purity. For brands developing skin-, hair-, or connective-tissue-focused formulations, our team can advise on peptide specifications, dosage ranges, and formulation compatibility to help match the right collagen source to your product goals.
